{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:05:44Z","timestamp":1778778344690,"version":"3.51.4"},"reference-count":33,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1248\/bpb.b18-00019","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T18:55:12Z","timestamp":1535741712000},"page":"1348-1354","source":"Crossref","is-referenced-by-count":5,"title":["Molecular State of Active Pharmaceutical Ingredients in Ketoprofen Dermal Patches Characterized by Pharmaceutical Evaluation"],"prefix":"10.1248","volume":"41","author":[{"given":"Motoshige","family":"Azuma","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hisada","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Koide","sequence":"additional","affiliation":[{"name":"Division of Drugs, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Kemper","sequence":"additional","affiliation":[{"name":"Tornado Spectral Systems, Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Teikyo Heisei University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Suzuki","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Nihon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyofumi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Nihon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmaceutics, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ishizaki T, Sasaki T, Suganuma T, Horai Y, Chiba K, Watanabe M, Asuke W, Hoshi H. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration. <i>Eur. J. Clin. Pharmacol.<\/i>, <b>18<\/b>, 407\u2013414 (1980).","DOI":"10.1007\/BF00636794"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kokki H. Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients. <i>Paediatr. Drugs<\/i>, <b>12<\/b>, 313\u2013329 (2010).","DOI":"10.2165\/11534910-000000000-00000"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shinkai N, Korenaga K, Okumura Y, Mizu H, Yamauchi H. Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs. <i>Eur. J. Pharm. Biopharm.<\/i>, <b>78<\/b>, 415\u2013421 (2011).","DOI":"10.1016\/j.ejpb.2011.03.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Shinkai N, Korenaga K, Mizu H, Yamauchi H. Intra-articular penetration of ketoprofen and analgesic effects after topical patch application in rats. <i>J. Control. Release<\/i>, <b>131<\/b>, 107\u2013112 (2008).","DOI":"10.1016\/j.jconrel.2008.07.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) G\u00fcrol Z, Hekimo\u01e7lu S, Demirdamar R, \u015eumnu M. Percutaneous absorption of ketoprofen. I. <i>In vitro<\/i> release and percutaneous absorption of ketoprofen from different ointment bases. <i>Pharm. Acta Helv.<\/i>, <b>71<\/b>, 205\u2013212 (1996).","DOI":"10.1016\/0031-6865(96)00011-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Goosen C, du Plessis J, M\u00fcller DG, Janse van Rensburg LF. Correlation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAID\u2019s. <i>Int. J. Pharm.<\/i>, <b>163<\/b>, 203\u2013209 (1998).","DOI":"10.1016\/S0378-5173(97)00359-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Beetge E, du Plessis J, M\u00fcller DG, Goosen C, van Rensburg FJ. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID\u2019s on their transdermal absorption. <i>Int. J. Pharm.<\/i>, <b>193<\/b>, 261\u2013264 (2000).","DOI":"10.1016\/S0378-5173(99)00340-3"},{"key":"8","unstructured":"8) Kawai S, Uchida E, Kondo M, Ohno S, Obata J, Nawata Y, Sugimoto K, Oribe M, Nagaya I. Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. <i>J. Clin. Pharmacol.<\/i>, <b>50<\/b>, 1171\u20131179 (2010)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. <i>Pain Med.<\/i>, <b>11<\/b>, 535\u2013549 (2010).","DOI":"10.1111\/j.1526-4637.2010.00809.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Komatsu T, Sakurada T. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe. <i>Eur. J. Pharm. Sci.<\/i>, <b>47<\/b>, 890\u2013895 (2012).","DOI":"10.1016\/j.ejps.2012.08.016"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Cordero JA, Alarcon L, Escribano E, Obach R, Domenech J. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. <i>J. Pharm. Sci.<\/i>, <b>86<\/b>, 503\u2013508 (1997).","DOI":"10.1021\/js950346l"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sekiya I, Morito T, Hara K, Yamazaki J, Ju Y-J, Yagishita K, Mochizuki Y, Tsuji K, Muneta T. Ketoprofen absorption by muscle and tendon after topical or oral administration in patients undergoing anterior cruciate ligament reconstruction. <i>AAPS PharmSciTech<\/i>, <b>11<\/b>, 154\u2013158 (2010).","DOI":"10.1208\/s12249-009-9367-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mazi\u00e8res B. Topical ketoprofen patch. <i>Drugs R.D.<\/i>, <b>6<\/b>, 337\u2013344 (2005).","DOI":"10.2165\/00126839-200506060-00003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kawamura N, Shinkai N, Yamauchi H, Takayama S. Comparison of poultice-type and tape-type patches containing ketoprofen on human skin irritation. <i>J. Toxicol. Sci.<\/i>, <b>28<\/b>, 415\u2013425 (2003).","DOI":"10.2131\/jts.28.415"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kawamura N, Igarashi K, Kawakami J, Gotoh M, Saitoh H, Sasaki H, Shinkai N, Yamauchi H, Takayama S. Characteristics of transdermal topical delivery patch (MILTAX) containing the anti-inflammatory and analgestic drug, ketoprofen. <i>Drug Deliv. Syst.<\/i>, <b>18<\/b>, 459\u2013470 (2003).","DOI":"10.2745\/dds.18.459"},{"key":"16","unstructured":"16) Adachi H, Ioppolo F, Paoloni M, Santilli V. Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation. <i>Eur. Rev. Med. Pharmacol. Sci.<\/i>, <b>15<\/b>, 823\u2013830 (2011)."},{"key":"17","unstructured":"17) Ohtani M, Matsumoto M, Namiki M, Yamamura Y, Sugiura M, Uchino K. Evaluation of Pharmaceutical Equivalency between Genuine and Generic Ketoprofen Tape, Yakuzaigaku. <i>J. Pharm. Sci. Technol., Japan<\/i>, <b>71<\/b>, 120\u2013125 (2011), in Japanese."},{"key":"18","unstructured":"18) Pharmaceuticals and Medical Devices Agency. \u201cMedical Package Insert search,\u201d Mohrus patch: \u2039http:\/\/www.info.pmda.go.jp\/go\/pack\/2649729S2169_1_16\/\u203a."},{"key":"19","unstructured":"19) Pharmaceuticals and Medical Devices Agency. \u201cMedical Package Insert search,\u201d Patell patch: \u2039http:\/\/www.info.pmda.go.jp\/go\/pack\/2649729S2142_1_20\/\u203a."},{"key":"20","unstructured":"20) Pharmaceuticals and Medical Devices Agency. \u201cMedical Package Insert search,\u201d Teikoku ketoprofen patch: \u2039http:\/\/www.info.pmda.go.jp\/go\/pack\/2649729S2223_4_02\/\u203a."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Yokota M, Tokudome Y. Permeation of hydrophilic molecules across glycated skin is differentially regulated by the stratum corneum and epidermis-dernus. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 1383\u20131388 (2015).","DOI":"10.1248\/bpb.b15-00372"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Obata Y, Maruyama Y, Takayama K. The mode of promoting activity of <i>O<\/i>-ethylmenthol as a transdermal absorption enhancer. <i>Pharm. Res.<\/i>, <b>23<\/b>, 392\u2013400 (2006).","DOI":"10.1007\/s11095-005-9257-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Matsui R, Uchida S, Namiki N. <i>In vitro<\/i> and <i>in vivo<\/i> evaluation under finite conditions of a transdermal oil-in-water type emulsified formulation of propiverine hydrochloride. <i>Biol. Pharm. Bull.<\/i>, <b>37<\/b>, 1661\u20131667 (2014).","DOI":"10.1248\/bpb.b14-00450"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) \u00d6zl\u00fc C, Basan H, \u015eatana E, Erta\u015f N, G\u00f6\u011fer NG. Quantitative determination of ketoprofen in gels and ampules by using flow-injection UV spectrophotometry and HPLC. <i>J. Pharm. Biomed. Anal.<\/i>, <b>39<\/b>, 606\u2013611 (2005).","DOI":"10.1016\/j.jpba.2005.04.002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Flach CR, Moore DJ. Infrared and Raman imaging spectroscopy of <i>ex vivo<\/i> skin. <i>Int. J. Cosmet. Sci.<\/i>, <b>35<\/b>, 125\u2013135 (2013).","DOI":"10.1111\/ics.12020"},{"key":"26","unstructured":"26) Liu C, Hui M, Quan P, Fang L. Drug in adhesive patch of palonosetron: Effect of pressure sensitive adhesive on drug skin permeation and <i>in vitro<\/i>\u2013<i>in vivo<\/i> correlation. <i>Int. J. Pharm.<\/i>, <b>511<\/b>, 1088\u20131097 (2016)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Liu C, Quan P, Fang L. Effect of drug physicochemical properties on drug release and their relationship with drug skin permeation behaviors in hydroxyl pressure sensitive adhesive. <i>Eur. J. Pharm. Sci.<\/i>, <b>93<\/b>, 437\u2013446 (2016).","DOI":"10.1016\/j.ejps.2016.08.048"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Inoue K, Sugibayashi K. <i>In vivo<\/i> enhancement of transdermal absorption of ketotifen by supersaturation generated by amorphous form of the drug. <i>Eur. J. Pharm. Sci.<\/i>, <b>47<\/b>, 228\u2013234 (2012).","DOI":"10.1016\/j.ejps.2012.06.006"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Marsac PJ, Li T, Taylor LS. Estimation of drug\u2013polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. <i>Pharm. Res.<\/i>, <b>26<\/b>, 139\u2013151 (2008).","DOI":"10.1007\/s11095-008-9721-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Rumondor ACF, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. <i>Pharm. Res.<\/i>, <b>26<\/b>, 2599\u20132606 (2009).","DOI":"10.1007\/s11095-009-9974-3"},{"key":"31","unstructured":"31) Wu PC, Chang JS, Huang YB, Chai CY, Tsai YH. Evaluation of percutaneous absorption and skin irritation of ketoprofen through rat skin: <i>in vitro<\/i> and <i>in vivo<\/i> study. <i>Int. J. Pharm.<\/i>, <b>222<\/b>, 225\u2013235 (2001)."},{"key":"32","unstructured":"32) Simon A, Amaro MI, Healy AM, Cabral LM, Sousa VP. Development of a discriminative <i>in vitro<\/i> release test for rivastigmine transdermal patches using pharmacopeial apparatuses: USP 5 and USP 6. <i>AAPS PharmSciTech<\/i>, <b>18<\/b>, 2561\u20132569 (2017)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Panchaxari DM, Pampana S, Pal T, Devabhaktuni B, Aravapalli AK. Design and characterization of diclofenac diethylamine transdermal patch using silicone and acrylic adhesives combination, DARU. <i>J. Pharm. Sci.<\/i>, <b>21<\/b>, 6 (2013).","DOI":"10.1186\/2008-2231-21-6"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/9\/41_b18-00019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T06:10:49Z","timestamp":1571811049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/9\/41_b18-00019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00019","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}